Annual Asia Pharmaceutical Regulatory Summit 2012

IBC’s focus in 2012 for its Pharmaceutical Regulatory Summit is to provide a platform for open discussion among the field including industry and authority professionals about common issues and challenges with regulatory approval in Asia and moving forward with strategies for the efficient approval of safe drugs. Frank discussions on what is required to get your products

Keynote Speakers:

Dr. Meir-Chyun Tzou,Prof. Andrea Laslop,Ms. Rinrata Wongviwatchai,Ashley Preston,Dr. Kyung Won Jang,Dong Zhao,Stefano Accorsi,Dr. Kyung Won Jang and many more.

For 2012 we’ve listened to your needs and have a new look agenda:

-More regulatory presentations from senior officials and authority decision makers

-Removed country-by-country checklist presentations of information that can be found on websites

-More interactive sessions through round-tables, Q&A’s, panels and discussion den

-More experience-based presentations going into detail about specific issues and challenges faced and how these were overcome

Why You Cant Afford To Miss This Event

-Critical insights into how regulators themselves interpret the guidelines and what you need to be compliant: Perspectives from BPOM (Indonesia), KFDA (Korea), TFDA (Taiwan), MHLW (Japan) and HKAPI (Hong Kong)

-Enhance your profitability by understanding successful regulatory approvals for key Asian markets: China, India, Indonesia and Korea

-Meet regulatory professionals from a range of MNCs including: Pfi zer, Chiesi, Biogen Idec, Allergan, Nycomed, Sanofi -Aventis, GlaxoSmithKline, MSD, Takeda & Hospira

- Learn from real-life challenges and regulatory solutions from country-specifi c experts including: Takeda Thailand, Pfizer China R&D Center, Biogen Idec Biotech India & Pfizer Indonesia

-Valuable perspectives on current priorities in regulated markets